Immunometabolic Stress and Immune Suppression in Clear-Cell Renal Cell Carcinoma: Perspectives in Therapeutic Strategy
International Journal of Molecular Sciences · 04.07.2026 · 27 (13) · 6021
DOI: 10.3390/ijms27136021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.07.2026. Verfasst von Tuong-Vi Nguyen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences and Engineering, National Central University, 300 Zhongda Rd., Taoyuan 320317, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, National Health Research Institutes, China Medical University.
Abstract (Originalsprache)
Solid tumors frequently experience hypoxia during tumor progression, resulting in profound metabolic alterations. This phenomenon is particularly pronounced in clear-cell renal cell carcinoma (ccRCC) because of loss of the von Hippel–Lindau (VHL) tumor suppressor gene and constitutive activation of hypoxia-inducible factor (HIF) signaling. ccRCC is the most common subtype of kidney cancer, and durable therapeutic responses remain limited despite advances in immune checkpoint inhibition. Owing to its strong pseudohypoxic phenotype and extensive metabolic rewiring, ccRCC is widely regarded as a metabolic disease. These alterations generate a unique immune landscape characterized by abundant immune-cell infiltration together with profound T-cell dysfunction and exhaustion. This paradoxical “immune-hot yet immunosuppressed” phenotype is largely driven by hypoxia-associated immunometabolic reprogramming within tumor cells and the tumor microenvironment (TME). Several metabolic pathways are critically involved in this process, including lactate acidosis, arginine (Arg) depletion, tryptophan (Trp) depletion, kynurenine (Kyn)-mediated T-cell exhaustion, and adenosine-driven immune suppression. This review summarizes the current understanding of hypoxia-driven immunometabolic interactions in ccRCC and discusses how targeting these pathways may improve future therapeutic strategies against this aggressive malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences and Engineering, National Central University, 300 Zhongda Rd., Taoyuan 320317, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University (Taiwan), 91 Hsueh-Shih Rd., Taichung 404333, Taiwan.
ORCID-Profile: Tien Hsu
Förderung
- National Science and Technology Council
- National Health Research Institutes
- China Medical University
- National Science and Technology Council, Taiwan
- China Medical University, Taiwan
- National Health Research Institutes, Taiwan
Zitieren
APA
Nguyen, T. V., & Hsu, T. (2026). Immunometabolic Stress and Immune Suppression in Clear-Cell Renal Cell Carcinoma: Perspectives in Therapeutic Strategy. International Journal of Molecular Sciences, 27(13), 6021. https://doi.org/10.3390/ijms27136021
Vancouver
Nguyen TV, Hsu T. Immunometabolic Stress and Immune Suppression in Clear-Cell Renal Cell Carcinoma: Perspectives in Therapeutic Strategy. International Journal of Molecular Sciences. 2026;27(13):6021. doi:10.3390/ijms27136021
BibTeX
@article{Nguyen2026,
author = {Nguyen, Tuong-Vi and Hsu, Tien},
title = {Immunometabolic Stress and Immune Suppression in Clear-Cell Renal Cell Carcinoma: Perspectives in Therapeutic Strategy},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {6021},
doi = {10.3390/ijms27136021}
}
EUVIMED